Codexis (CDXS) FCF Margin Growth (5y) (2015 - 2026)

Codexis (CDXS) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Codexis 135.70 Mn 70.56 Mn 13.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,128.00
Dec 31, 2025 5,485.00
Sep 30, 2025 -6,077.00
Jun 30, 2025 -4,652.00
Mar 31, 2025 -18,466.00
Dec 31, 2024 -7,813.00
Sep 30, 2024 -9,002.00
Jun 30, 2024 -10,733.00
Mar 31, 2024 -3,303.00
Dec 31, 2023 -29,712.00
Sep 30, 2023 -11,391.00
Jun 30, 2023 -29,421.00
Mar 31, 2023 -6,061.00
Dec 31, 2022 2,843.00
Sep 30, 2022 10,913.00
Jun 30, 2022 6,428.00
Mar 31, 2022 2,203.00
Dec 31, 2021 -7,045.00
Sep 30, 2021 166,825.00
Jun 30, 2021 498.00